BR0300882A - Pharmaceutical compositions, method and use of formulation for treatment and prevention of infections associated with helicobacter pylori in mammals and humans - Google Patents

Pharmaceutical compositions, method and use of formulation for treatment and prevention of infections associated with helicobacter pylori in mammals and humans

Info

Publication number
BR0300882A
BR0300882A BR0300882-7A BR0300882A BR0300882A BR 0300882 A BR0300882 A BR 0300882A BR 0300882 A BR0300882 A BR 0300882A BR 0300882 A BR0300882 A BR 0300882A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
prevention
treatment
helicobacter pylori
mammals
Prior art date
Application number
BR0300882-7A
Other languages
Portuguese (pt)
Inventor
Jose Junior Pedrazzoli
Original Assignee
Cmax Otimizacao De Resultados
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cmax Otimizacao De Resultados filed Critical Cmax Otimizacao De Resultados
Priority to BR0300882-7A priority Critical patent/BR0300882A/en
Priority to AU2003287797A priority patent/AU2003287797A1/en
Priority to PCT/BR2003/000205 priority patent/WO2004089340A1/en
Publication of BR0300882A publication Critical patent/BR0300882A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/345—Nitrofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Abstract

"COMPOSIçõES FARMACêUTICAS, MéTODO E USO DE FORMULAçãO PARA TRATAMENTO E PREVENçãO DE INFECçõES ASSOCIADAS COM HELICOBACTER PYLORI EM MAMìFEROS E NO SER HUMANO". A presente invenção refere-se a composições farmacêuticas que associam antibióticos com inibidores de bomba protónica e suas aplicações para o tratamento e a prevenção de infecções causadas por Helicobacter pylori. Mais precisamente, a presente invenção refere-se a composições farmacêuticas de uso oral contendo três fármacos com atividade contra infecções de H. pylori, onde pelo menos um antibiótico é da classe de nitrofuranos associado a, pelo menos, um segundo antibiótico que pode ser da classe de macrolídeos ou tetraciclinas, associado a um inibidor de bomba protónica."PHARMACEUTICAL COMPOSITIONS, METHOD AND USE OF FORMULATION FOR TREATMENT AND PREVENTION OF INFECTIONS ASSOCIATED WITH HELICOBACTER PYLORI IN MAMMALS AND HUMAN". The present invention relates to pharmaceutical compositions which associate antibiotics with proton pump inhibitors and their applications for the treatment and prevention of Helicobacter pylori infections. More precisely, the present invention relates to oral pharmaceutical compositions containing three drugs having activity against H. pylori infections, wherein at least one antibiotic is of the nitrofuran class associated with at least one second antibiotic which may be of the macrolide or tetracycline class associated with a proton pump inhibitor.

BR0300882-7A 2003-04-09 2003-04-09 Pharmaceutical compositions, method and use of formulation for treatment and prevention of infections associated with helicobacter pylori in mammals and humans BR0300882A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
BR0300882-7A BR0300882A (en) 2003-04-09 2003-04-09 Pharmaceutical compositions, method and use of formulation for treatment and prevention of infections associated with helicobacter pylori in mammals and humans
AU2003287797A AU2003287797A1 (en) 2003-04-09 2003-12-29 Pharmaceutical compositions, method, and use of formulation for the treatment and prevention of infections associated with helicobacter pylori in mammals and humans
PCT/BR2003/000205 WO2004089340A1 (en) 2003-04-09 2003-12-29 Pharmaceutical compositions, method, and use of formulation for the treatment and prevention of infections associated with helicobacter pylori in mammals and humans

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0300882-7A BR0300882A (en) 2003-04-09 2003-04-09 Pharmaceutical compositions, method and use of formulation for treatment and prevention of infections associated with helicobacter pylori in mammals and humans

Publications (1)

Publication Number Publication Date
BR0300882A true BR0300882A (en) 2005-05-10

Family

ID=33136628

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0300882-7A BR0300882A (en) 2003-04-09 2003-04-09 Pharmaceutical compositions, method and use of formulation for treatment and prevention of infections associated with helicobacter pylori in mammals and humans

Country Status (3)

Country Link
AU (1) AU2003287797A1 (en)
BR (1) BR0300882A (en)
WO (1) WO2004089340A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR056062A1 (en) 2006-06-05 2007-09-19 Bago Sa Labor ANTI-AGED PHARMACEUTICAL COMPOSITION IN DUST FORM, PHARMACEUTICAL PREPARATION THAT UNDERSTANDS IT AND PROCESS FOR PREPARATION
WO2008114143A1 (en) * 2007-03-22 2008-09-25 Aurobindo Pharma Limited Extended release formulations of macrolide antibiotic
WO2011079349A1 (en) * 2009-12-31 2011-07-07 Okada Medical Services Pty Ltd Okadaella gastrococcus and cancer
BR202014031413U2 (en) * 2014-12-15 2016-06-21 Ems Sa kit for joint drug administration

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US6132768A (en) * 1995-07-05 2000-10-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors

Also Published As

Publication number Publication date
AU2003287797A1 (en) 2004-11-01
WO2004089340A1 (en) 2004-10-21

Similar Documents

Publication Publication Date Title
BR0307755A (en) Treating colds and coughs with a combination of a selective cyclooxygenase-2 inhibitor and an active ingredient against colds and coughs and their compositions.
BR0109912A (en) New anthelmintic combinations
BRPI0408999A (en) compressed prolonged oral release multiparticulate tablets
BR0107147A (en) Pharmaceutical compositions of anti-tuberculosis drugs and process for their preparations
BRPI0414876A (en) pharmaceutical compounds and compositions for the prevention of overdose or abuse and their uses
BR0013010A (en) Formulation of moxifloxacin sodium chloride
BRPI0515896A (en) a compound or a pharmaceutically acceptable salt or ester thereof, a method for treating or prophylaxis a host infected with a flavivirus, pestivirus or hepacivirus infection, and a pharmaceutical composition for treating a host infected with a flavivirus, pestivirus or hepacivirus
BR0308289A (en) Florfenicol Antibiotics
BRPI0514536A (en) use of nondigestible oligosaccharides and digestible galactose saccharide, and suitable composition for the treatment and / or prevention of respiratory tract infections and / or respiratory tract infection disease
BR0012590A (en) Compound, process for its preparation, pharmaceutical formulation, use of a compound, and, methods for treatment or prophylaxis of pain or discomfort, and for treatment or prophylaxis of neuropathic or central pain
BR0307898A (en) Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride
BRPI0518266A2 (en) modified-release oral medicinal product of at least one active ingredient in multi-capsule form
NO20000314D0 (en) Pharmaceutical compositions containing lysostaphin alone or in combination with an antibiotic for the treatment of staphylococcal infections
BR0211814A (en) Formulation containing (lyso) phosphatidylserine for the prevention and treatment of stress states in warm-blooded animals
BR0314763A (en) Treatment of fungal infections
BR0109931A (en) Pharmaceutical Compositions
BRPI0518255A2 (en) Methods of treating or preventing a central nervous system injury to reduce or prevent an adverse effect, and pharmaceutical composition
BRPI0415953A (en) oral controlled release dosage formulation, method of treating a disorder, set of controlled release dosage forms and method for administering the formulation
BRPI0608334A2 (en) use of a powdered clobetasol formulation for the treatment of psoriasis
DE50114474D1 (en) COMBINATION OF A TRANSDERMAL THERAPEUTIC SYSTEM AND ORAL AND / OR PARENTERAL PREPARATION CONTAINING DOPAMINAGONISTS FOR THE TREATMENT OF DOPAMINERGER ILLNESSES
BRPI0415753A (en) method for treating and preventing respiratory inflammation with a cyclooxygenase-2 inhibitor in combination with a phosphodiesterase 4 inhibitor and compositions containing them
KR970061244A (en) Pharmaceutical composition for treating dementia
BR0309757A (en) 6-alkylidene bicyclic penenes as beta-lactamase inhibitors
BR0210744A (en) Synergistically Pharmaceutical Combination for the Prevention or Treatment of Diabetes
BRPI0414305A (en) oral drug delivery system

Legal Events

Date Code Title Description
B04C Request for examination: reinstatement - article 33, solely paragraph, of industrial property law
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 4A, 6A E 7A ANUIDADES

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO PUBLICADO 8.6 DA RPI 2038 DE 26/01/2010.